Invasive Treatment for Stable CAD: Is There a Cardiac Mortality Benefit?

email article
Patients with stable coronary artery disease (CAD) who underwent coronary revascularization had the benefit of decreased cardiac mortality in subsequent years, according to a meta-analysis pooling ISCHEMIA, COURAGE, and other randomized trials.
Cardiac mortality risk was reduced in revascularized patients compared with peers assigned to medical therapy alone (RR 0.79, 95% CI 0.67-0.93), reported Eliano Navarese, MD, PhD, of Nicolaus Copernicus University in Toruń, Poland, at the virtual European Association of Percutaneous Cardiovascular Interventions (EuroPCR) meeting.
"The benefits of revascularization and of optimized medical therapy are additive and the combination is required to achieve maximal and durable prevention of adverse events," Navarese said.

Related Keywords

Ann Arbor ,Michigan ,United States ,Poland ,Nicole Lou ,Eliano Navarese ,Eric Bates ,Nicolaus Copernicus University In Toru ,Peuropean Association Of Percutaneous Cardiovascular Interventions Euro ,University Of Michigan ,Nicolaus Copernicus University ,European Association ,Percutaneous Cardiovascular Interventions ,European Heart ,Medpage Today ,ஆண்டு ஆர்பர் ,மிச்சிகன் ,ஒன்றுபட்டது மாநிலங்களில் ,போல்யாஂட் ,நிக்கோல் லூ ,எரிக் பேட்ஸ் ,பல்கலைக்கழகம் ஆஃப் மிச்சிகன் ,நிக்கோலஸ் கோப்பர்நிக்கஸ் பல்கலைக்கழகம் ,ஐரோப்பிய சங்கம் ,ஐரோப்பிய இதயம் ,